The role of GSK-3 in synaptic plasticity.

Abstract : Glycogen synthase kinase-3 (GSK-3), an important component of the glycogen metabolism pathway, is highly expressed in the CNS. It has been implicated in major neurological disorders including Alzheimer's disease, schizophrenia and bipolar disorders. Despite its central role in these conditions it was not known until recently whether GSK-3 has neuronal-specific functions under normal conditions. However recent work has shown that GSK-3 is involved in the regulation of, and cross-talk between, two major forms of synaptic plasticity, N-methyl-D-aspartate receptor (NMDAR)-dependent long-term potentiation (LTP) and NMDAR-dependent long-term depression (LTD). The present article summarizes this recent work and discusses its potential relevance to the treatment of neurological disorders.
Type de document :
Article dans une revue
British Journal of Pharmacology, Wiley, 2008, 153 Suppl 1, pp.S428-37. 〈10.1038/bjp.2008.2〉
Liste complète des métadonnées

Littérature citée [60 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00777058
Contributeur : Stephane Peineau <>
Soumis le : mercredi 16 janvier 2013 - 17:08:23
Dernière modification le : mercredi 16 janvier 2013 - 18:22:02
Document(s) archivé(s) le : samedi 1 avril 2017 - 06:24:14

Fichier

bjp_HAL.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Stéphane Peineau, Clarrisa Bradley, Changiz Taghibiglou, Andrew Doherty, Zuner Bortolotto, et al.. The role of GSK-3 in synaptic plasticity.. British Journal of Pharmacology, Wiley, 2008, 153 Suppl 1, pp.S428-37. 〈10.1038/bjp.2008.2〉. 〈inserm-00777058〉

Partager

Métriques

Consultations de la notice

153

Téléchargements de fichiers

212